This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (17)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Genetic Disorders  • Dementias  • Neurogenetics  • Alert me on articles by topic

Rodney A. Short, MD; Neill R. Graff-Radford, MBBCh, FRCP(London); Jennifer Adamson, BS; Matt Baker, BS; Mike Hutton, PhD

Arch Neurol. 2002;59:611-615.

Background  Frontotemporal lobar degeneration (FTLD) has different clinical phenotypes and is associated with several pathologic findings, most commonly dementia lacking distinctive histology or Pick disease. We know that the tau H1 haplotype is associated with some clinical and histologic phenotypes, for example, progressive supranuclear palsy and corticobasal degeneration. Furthermore, the apolipoprotein 4 allele (APOE 4) may be associated with Pick disease.

Objective  To determine if different clinical phenotypes of FTLD are associated with different tau haplotype and APOE allele frequencies.

Patients and Methods  All patients with FTLD with available DNA specimens (n = 63) seen at the Mayo Clinic, Jacksonville, Fla, were retrospectively classified according to the following clinical phenotypes: frontal dementia (FD); progressive, nonfluent aphasia (PA); or fluent, anomic aphasia (AA). DNA specimens were genotyped for APOE allele and tau haplotype frequencies and were compared with cognitively normal patients (n = 338) and patients with Alzheimer disease (AD) (n = 193).

Results  Patients with AA had increased APOE 4 frequency (30.4%) compared with patients with FD (14.8%, P = .04) and cognitively normal patients (11.1%, P<.001). Patients with AA also had increased tau H2 haplotype (37.0%) frequency compared with patients with FD (11.1%,P = .002), patients with AD (21.8%, P = .02), and cognitively normal patients (19.8%, P = .004). The increase in tau H2 haplotype frequency (50.0%) is especially pronounced in patients with AA who are APOE 4 positive compared with patients with FD (18.8%, P = .04), patients with AD (24.8%, P = .005), and cognitively normal patients (15.3%, P<.001). APOE 4 and tau H2 haplotype frequencies are not significantly different in patients with FD and PA compared with healthy patients.

Conclusions  Clinical subtypes of FTLD have different tau and APOE genotype frequencies, suggesting these genes may influence the clinical presentation. Further studies should be performed to confirm this finding and to see if the pathologic phenotypes are also associated with different tau and APOE genotype frequencies.

From the Departments of Neurology (Drs Short and Graff-Radford) and Neuroscience (Ms Adamson, Mr Baker, and Dr Hutton), Mayo Clinic, Jacksonville, Fla.

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(4):655-656.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The apolipoprotein E {varepsilon}4 allele selectively increases the risk of frontotemporal lobar degeneration in males
Srinivasan et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:154-158.
ABSTRACT | FULL TEXT  

Association Between Tau H2 Haplotype and Age at Onset in Frontotemporal Dementia
Borroni et al.
Arch Neurol 2005;62:1419-1422.
ABSTRACT | FULL TEXT  

Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy
Tang-Wai et al.
Neurology 2004;63:1168-1174.
ABSTRACT | FULL TEXT